major depressive disorder

failure crash no fail rocket cancelled end
Biotech

Alto's midphase depression trial falls flat

A phase 2b trial of Alto’s lead drug candidate in depression missed its primary and key secondary endpoints, wiping 60% off the biotech’s share price.
Nick Paul Taylor Oct 23, 2024 4:47am
Man on chair with head in hand

Supernus links depression drug to fast responses in ph. 2 trial

Oct 18, 2024 9:17am
brain amyloid alzheimers strings detailed web complicated thought

Abbott begins neuromodulation trial in drug-resistant depression

Sep 4, 2024 11:02am
sleep insomnia clock depression sad

J&J's oral add-on aces phase 3 in major depressive disorder

May 29, 2024 11:55am
pills prescription

Neurocrine-Takeda antidepressant hits main mark in phase 2 trial

Apr 23, 2024 10:44am
Front view of unrecognizable mature woman sitting at the table and typing a text message on her smart phone

FDA clears Otsuka, Click's prescription app for depression

Apr 3, 2024 1:53pm